COMPANY

Third Arc Bio

HQ: Lower Gwynedd, PA source · thirdarcbio.com ↗

Keywords: immunology ARC101

Location: Lower Gwynedd, PA · source · Aug 1, 2024

Profile checked Oct 10, 2026

Raises and deals from press releases

Raise Series A · $52M · announced Feb 4, 2026 Company release ↗
Source quote
- Feb 4, 2026 · Company release ↗
  “$52M equity adds to previously announced $165M Series A New investor Andreessen Horowitz (a16z) leads the financing with founding investor Omega Funds; additional investors include Life Sciences at Goldman Sachs Alternatives, BVF Partners LP, funds managed by abrdn.”

Raises announced in these releases: $52M disclosed.

From the company’s own releases; this list is partial. All raises and deals

May 1, 2028 (ESTIMATED) · Phase 1 · ARC101 in Advanced Solid Tumors · NCT06672185

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT06672185	ARC101 in Advanced Solid Tumors	Phase 1	Recruiting	Feb 5, 2025	May 1, 2028 (estimated)